NUWIQ is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Octapharma Usa Inc. The primary component is .
| Product ID | 68982-151_052ca8a8-a25d-2ea0-9080-b49091286057 |
| NDC | 68982-151 |
| Product Type | Plasma Derivative |
| Proprietary Name | NUWIQ |
| Generic Name | Antihemophilic Factor (recombinant) |
| Dosage Form | Kit |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-08-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125555 |
| Labeler Name | Octapharma USA Inc |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2017-08-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125555 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2017-08-01 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68982-139 | NUWIQ | NUWIQ |
| 68982-143 | NUWIQ | NUWIQ |
| 68982-147 | NUWIQ | NUWIQ |
| 68982-149 | NUWIQ | NUWIQ |
| 68982-141 | NUWIQ | NUWIQ |
| 68982-145 | NUWIQ | NUWIQ |
| 68982-151 | NUWIQ | NUWIQ |
| 0026-3782 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3783 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3785 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3786 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3787 | Kogenate FS | Antihemophilic Factor (Recombinant) |
| 0026-3821 | Kovaltry | Antihemophilic Factor (Recombinant) |
| 0026-3822 | Kovaltry | Antihemophilic Factor (Recombinant) |
| 0026-3824 | Kovaltry | Antihemophilic Factor (Recombinant) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NUWIQ 79138098 4496748 Live/Registered |
Octapharma AG 2013-08-09 |